drug

TARA-002

1 story · latest Aug 11, 2026

Status: Investigational
Trials: 3 registered trials in coverage

Relationships

Developed by Protara Therapeutics

Timeline

Protara reports Q2 2026 results, redesigns ADVANCED-3 trial for TARA-002

Aug 11Quarterly updateProtara Therapeutics TARA-002

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.